conditionally replicating oncolytic adenovirus therapy targeting p21/Waf-1 (Johns Hopkins University)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameconditionally replicating oncolytic adenovirus therapy targeting p21/Waf-1 (Johns Hopkins University)
Drug Alias NameCRAds (Johns Hopkins University)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A